SuzanneOparilMD
Cardiology • Birmingham, ALProfessor, Medicine, University of Alabama School of Medicine
Dr. Oparil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-934-1302
Summary
- Director, Vascular Biology & Hypertension Program
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1969 - 1970
Boston University Medical CenterResidency, Internal Medicine, 1968 - 1969- Massachusetts General HospitalResidency, Internal Medicine, 1967 - 1968
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1965 - 1967
Columbia University Vagelos College of Physicians and SurgeonsClass of 1965
Certifications & Licensure
IL State Medical License 1971 - Present
AL State Medical License 1977 - 2023- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Women's Health Castle Connolly, 2008
- Men's Health Castle Connolly, 2007
- Join now to see all
Clinical Trials
- The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy Start of enrollment: 2008 Mar 01
- Systolic Blood Pressure Intervention Trial Start of enrollment: 2010 Oct 01
- Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 704 citationsEffectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 UpdateLori Mosca, Emelia J. Benjamin, Kathy Berra, Judy L. Bezanson, Rowena J. Dolor
Journal of the American College of Cardiology. 2011-03-22 - 32 citationsLonger-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.Byron C Jaeger, Adam P Bress, Joshua D Bundy, Alfred K Cheung, William C Cushman
JAMA Cardiology. 2022-11-01 - 5 citationsSympathetic Neural Mechanisms in Hypertension: Recent Insights.Guido Grassi, Raffaella Dell'Oro, Fosca Quarti-Trevano, Jennifer Vanoli, Suzanne Oparil
Current Hypertension Reports. 2023-10-01
Journal Articles
- Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical PracticeSuzanne Oparil, Mark A Parkulo, Priscilla Pemu, Paul K Whelton, JAMA Internal Medicine
- Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with HypertensionFranz H Messerli, George C Roush, Suzanne Oparil, JAMA Internal Medicine
- PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINTUdayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
- Join now to see all
Authored Content
- Chlorthalidone and Hydrochlorothiazide for Treatment of Patients with HypertensionJune 2020
Press Mentions
David Sibley, MD Began His Career with a Diagnostic BreakthroughFebruary 21st, 2023- Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISIONNovember 9th, 2022
- AHA 2022 – Idorsia and Cincor move forward in hypertensionNovember 8th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
